Literature DB >> 20043604

High proportion of influenza B characterises the 2008 influenza season in Victoria.

Kristina A Grant1, Kylie Carville, James E Fielding, Ian G Barr, Michaela A Riddell, Thomas Tran, Heath A Kelly.   

Abstract

The 2008 influenza season in Victoria was distinctive because of the increased proportion of influenza-like illness (ILI) cases due to influenza B infection and the lateness of the season compared with preceding years. Influenza activity fell within the bounds of normal seasonal activity thresholds. The average rate of ILI reported by general practitioners participating in sentinel surveillance was 5.5 cases per 1,000 consultations, peaking at 13.4 cases per 1,000 consultations. The average ILI rate reported by the Melbourne Medical Deputising Service was 5.1 cases per 1,000 consultations over the season peaking at 16.2 cases per 1,000 consultations at the same time as peak rates were reported by rural geneal practitioners (GPs), with a secondary peak observed 2 weeks later (10.9 cases per 1,000 consultations). Metro GP rates peaked in week 35 (week beginning 25 August) at 15.2 cases per 1,000 consultations. Influenza B cases notified directly to the Victorian Department of Human Services (DHS) from other sources peaked in the 1st week of September with peak numbers of influenza A notifications occurring the following week. Overall 56% of notifications of laboratory confirmed influenza to DHS and 56% of influenza positive swabs from sentinel surveillance were influenza type B.

Entities:  

Mesh:

Year:  2009        PMID: 20043604

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  14 in total

Review 1.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

2.  Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission.

Authors:  Clare Looker; Kylie Carville; Kristina Grant; Heath Kelly
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

3.  Reality check of laboratory service effectiveness during pandemic (H1N1) 2009, Victoria, Australia.

Authors:  Michael Catton; Julian Druce; Goergina Papadakis; Thomas Tran; Christopher Birch
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

4.  Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Authors:  James E Fielding; Kristina A Grant; Georgina Papadakis; Heath A Kelly
Journal:  BMC Infect Dis       Date:  2011-06-14       Impact factor: 3.090

5.  All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009.

Authors:  David J Muscatello; Michelle A Cretikos; C Raina Macintyre
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

Review 6.  The rationale for quadrivalent influenza vaccines.

Authors:  Christopher S Ambrose; Myron J Levin
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

7.  Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012.

Authors:  Jean Marie Cohen; Maria Laura Silva; Saverio Caini; Meral Ciblak; Anne Mosnier; Isabelle Daviaud; Gonçalo Matias; Selim Badur; Martine Valette; Vincent Enouf; John Paget; Douglas M Fleming
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

8.  The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012.

Authors:  Hongjie Yu; Jigui Huang; Yang Huai; Xuhua Guan; John Klena; Shali Liu; Youxing Peng; Hui Yang; Jun Luo; Jiandong Zheng; Maoyi Chen; Zhibin Peng; Nijuan Xiang; Xixiang Huo; Lin Xiao; Hui Jiang; Hui Chen; Yuzhi Zhang; Xuesen Xing; Zhen Xu; Zijian Feng; Faxian Zhan; Weizhong Yang; Timothy M Uyeki; Yu Wang; Jay K Varma
Journal:  Influenza Other Respir Viruses       Date:  2013-11-10       Impact factor: 4.380

9.  Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial.

Authors:  Joanne M Langley; Otto G Vanderkooi; Hartley A Garfield; Jacques Hebert; Vijayalakshmi Chandrasekaran; Varsha K Jain; Louis Fries
Journal:  J Pediatric Infect Dis Soc       Date:  2012-03-01       Impact factor: 3.164

10.  Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study.

Authors:  Saverio Caini; Q Sue Huang; Meral A Ciblak; Gabriela Kusznierz; Rhonda Owen; Sonam Wangchuk; Cláudio M P Henriques; Richard Njouom; Rodrigo A Fasce; Hongjie Yu; Luzhao Feng; Maria Zambon; Alexey W Clara; Herman Kosasih; Simona Puzelli; Herve A Kadjo; Gideon Emukule; Jean-Michel Heraud; Li Wei Ang; Marietjie Venter; Alla Mironenko; Lynnette Brammer; Le Thi Quynh Mai; François Schellevis; Stanley Plotkin; John Paget
Journal:  Influenza Other Respir Viruses       Date:  2015-08       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.